Learning from Regional Successes: Strengthening Afghanistan's Pharmaceutical Supply Chain through the Experiences of Pakistan, Iran, and India
DOI:
https://doi.org/10.59653/ijmars.v3i03.1907Keywords:
Pharmaceutical Supply Chain Management (PSCM), Afghanistan, Regional Success, Post-War Recovery, Pakistan, Iran, India, Supply Chain Strengthening, Healthcare InfrastructureAbstract
This research examines the challenges confronting Afghanistan's pharmaceutical supply chain management (PSCM) in the aftermath of prolonged conflict, with an emphasis on enhancing access to essential medicines. The Afghan pharmaceutical sector is characterized by systemic inefficiencies, regulatory shortcomings, inadequate infrastructure, and disruptions stemming from years of instability. Drawing insights from the experiences of neighboring countries—Pakistan, Iran, and India—that have navigated similar obstacles, this study identifies strategic interventions to fortify Afghanistan’s PSCM. This research follows a qualitative method and a deductive approach. Key recommendations include strengthening regulatory frameworks to ensure the quality and safety of pharmaceuticals, leveraging digital technologies for improved inventory and distribution management, and enhancing cold chain infrastructure for temperature-sensitive products. The role of centralized procurement systems and public-private partnerships (PPPs) is underscored as vital for increasing efficiency and reducing costs. Furthermore, fostering local pharmaceutical manufacturing is proposed as a crucial step toward self-sufficiency and resilience. By adapting successful strategies from its neighbors to its distinct context, Afghanistan can develop a more robust, transparent, and sustainable pharmaceutical supply chain, ultimately improving public health outcomes and ensuring consistent access to life-saving medications.
Downloads
References
Aboulhallaj, M., Mousavi, S. M., Jafari, M., Vosoogh-Moghaddam, A., Bahariniya, S., Ghasemyani, S., & Far, S. S. T. (2024). Challenges and executive requirements of advanced health system governance based on general health policies in Iran: qualitative research. BMC Health Services Research, 24(1), 1517. https://doi.org/10.1186/s12913-024-11887-z
Brahmbhatt, S., & Misra, H. Ajay Bhaskarabhatla, Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics). Springer International Publishing, 2018, pp. ix-306,€ 109.99. ISBN: 978-3-319-93392-4.
Bhaskarabhatla, A. (2018). Regulating Pharmaceutical Prices in India Policy Design, Implementation and Compliance. (India Studies in Business and Economics 2198-0012 ed.) Springer-Verlag. India Studies in Business and Economics Vol. 2198-0012 https://doi.org/10.1007/978-3-319-93393-1
Banerjee, A. V., & Duflo, E. (2019). Good economics for hard times: Better answers to our biggest problems. PublicAffairs. https://gdsnet.org/BanerjeeandDufloGoodEconomicsforHardtimes2019.pdf
Coyle, J. J., Bardi, E. J., & Langley, C. J. (2020). The management of business logistics: A supply chain perspective (10th ed.). Cengage Learning. https://books.google.com.af/books/about/The_Management_of_Business_Logistics.html?id=6xxlQgAACAAJ&redir_esc=y
Farooq, F., Khan, J., & Khan, M. U. G. (2020). Effect of Lockdown on the spread of COVID-19 in Pakistan. arXiv preprint arXiv:2005.09422. https://doi.org/10.48550/arXiv.2005.09422
Foreign Policy Analytics & Chemonics. (2023, April). Strengthening supply chain resilience to safeguard health in low- and middle-income countries. Foreign Policy Analytics. fpanalytics.foreignpolicy.com
Global Fund. (2021). Building Resilience in Health Systems: Lessons from India’s Pharmaceutical Supply Chain. Retrieved from https://www.theglobalfund.org/en/impact/health-systems-strengthening
Ghiasvand, H., Mohamadi, E., Olyaeemanesh, A., Kiani, M. M., Armoon, B., & Takian, A. (2021). Health equity in Iran: A systematic review. Medical journal of the Islamic Republic of Iran, 35, 51. https://doi.org/10.47176/mjiri.35.51
https://www.undp.org/india/projects/improving-vaccination-systems-evin
https://wdr.unodc.org/wdr2020/en/index2020.html
https://www.unicef.org/supply/supply-annual-report-2021
Iqbal, M. A., & Younas, M. Z. (2021). Public knowledge, attitudes, and practices towards COVID-19 in Pakistan: A cross-sectional study. Children and Youth Services Review, 120, 105784. https://doi.org/10.1016/j.childyouth.2020.105784
Kumar, D., Lohani, P., Kumar, A., Ahmad, S., & Kumar, P. (2019). Electronic Vaccine Intelligence Network (eVIN): Are Cold Chain Handlers Supporting this m Health? An Application of Kurt Lewin Theory of Change Management. International Journal of Health Systems and Implementation Research, 3(1), 33-40.
MACDONALD, D. (2017). Drugs in Afghanistan. In Drugs in Afghanistan. https://doi.org/10.2307/j.ctt18dzt2f
Ministry of Public Health (Afghanistan). (2020). Afghanistan National Medicines Policy. Kabul: Ministry of Public Health.
Nanda, L., Bouchet, B., Bratt, J., & Searle, S. (2010). The Role of Public–Private Partnerships in Strengthening Health Systems. https://www.fhi360.org/wp-content/uploads/drupal/documents/resource-public-private-partnerships-health-systems-strengthening.pdf
Nemat, A., Yasmin, F., Essar, M. Y., Raufi, N., Ahmad, S., Asady, A., & Zeng, Q. (2022). Public Perception and Preparedness to Fight Against the Third Wave of COVID-19 in Kabul, Afghanistan. Inquiry (United States), 59. https://doi.org/10.1177/00469580221117743
Ozawa, S., Evans, D. R., Bessias, S., Haynie, D. G., Yemeke, T. T., Laing, S. K., & Herrington, J. E. (2018). Prevalence and estimated economic burden of substandard and falsified medicines in low-and middle-income countries: a systematic review and meta-analysis. JAMA network open, 1(4), e181662-e181662.
Panhwar, M. A. (2021). MCC: integration mobile cloud computing of big data for health-care analytics enhance. PSYCHOLOGY AND EDUCATION, 58(2), 3398-3405.
Roien, R., Shrestha, R., Yadav, K., Ozaki, A., Ahmadi, M. B., Kaneda, Y., Kotera, Y., Sapkota, B., & Shrestha, S. (2022). An assessment of adherence to the WHO-delineated good manufacturing practice by the pharmaceutical companies in Kabul, Afghanistan. Cost Effectiveness and Resource Allocation, 20(1). https://doi.org/10.1186/s12962-022-00348-1
Roien, R., Essar, M. Y., Ahmadi, A., … et al. (2021). Challenges of drug supply: How Afghanistan is struggling. Public health in practice (Oxford, England), 2, 100129. https://doi.org/10.1016/j.puhip.2021.100129
Roy, S., Dhaneshwar, S., & Bhasin, B. (2020). Drug repurposing: an emerging tool for drug reuse, recycling and discovery. Current Drug Research Reviews Formerly: Current Drug Abuse Reviews, 13(2), 101-119. https://doi.org/10.2174/2589977513666210211163711
Rault-Chodankar, Y. M., & Kale, D. (2023). ‘Manufacturers without factories’ and economic development in the Global South: India’s pharmaceutical firms. Journal of Economic Geography, 23(2), 319-341. https://doi.org/10.1093/jeg/lbac013
Salehi, A. S., Saljuqi, A. T. K., Akseer, N., Rao, K., & Coe, K. (2018). Factors influencing performance by contracted non-state providers implementing a basic package of health services in Afghanistan. International Journal for Equity in Health, 17(1). https://doi.org/10.1186/s12939-018-0847-4
Sharma, R. K., Bhalla, N., & Goyal, A. (2022). Investigating critical factors that encourage public‐private partnership in infrastructure projects in emerging economies: Evidence from the Republic of India. Journal of Public Affairs, 22(4), e2713. https://doi.org/10.1002/pa.2713
Sajadi, H. S., & Majdzadeh, R. (2022). Health system to response to economic sanctions: global evidence and lesson learned from Iran. Globalization and Health, 18(1), 107. https://doi.org/10.1186/s12992-022-00901-w
Shahbahrami, E., Kalhor, R., Amerzadeh, M., Hasani, M., & Kiani, M. (2024). A dynamic management model for sustainable drug supply chain in hospital pharmacies in Iran. BMC Health Services Research, 24, 1205. https://doi.org/10.1186/s12913-024-11692-8
Tehran Times. (2019, July 22). Iran able to produce 90% of needed pharma raw materials. Tehran Times. https://www.tehrantimes.com/news/438445/Iran-able-to-produce-90-of-needed-pharma-raw-materials-VP
United Nations Office for Project Services (UNOPS). (2021). Improving Pharmaceutical Distribution in Conflict Zones: A Case Study of Afghanistan. UNOPS Report. Retrieved from https://www.unops.org/afghanistan
World Health Organization. (2016). Addressing the global shortage of, and access to, medicines and vaccines. EB142/13. https://apps.who.int/gb/ebwha/pdf_files/EB142/B142_13-en.pdf
World Bank. (2022). Pharmaceutical Supply Chain Management in South Asia: Regional Collaboration and Challenges. Retrieved from https://www.worldbank.org/psc/supply-chain-south-asia
World Health Organization (WHO). (2019). Strengthening Pharmaceutical Supply Chains in Low-Income Countries. Geneva: World Health Organization. Retrieved from https://www.who.int/health-topics/pharmaceutical-supply-chain
Zaidi, S., Salam, R., Bhutta, Z. A., Ansari, S., Rizvi, S. S., Zehra, B. F., Pethani, A. (2013). Public private partnerships for improving maternal and neonatal health service delivery a review of the evidence. Research and Advocacy Fund, British Council Islamabad, 1-70.
Zaidi, S. A., Bigdeli, M., Langlois, E. V., Riaz, A., Orr, D. W., Idrees, N., & Bump, J. B. (2019). Health systems changes after decentralisation: progress, challenges and dynamics in Pakistan. BMJ global health, 4(1), e001013. https://doi.org/10.1136/bmjgh-2018-001013
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Hamdullah Azimi, Mohammad Yusuf Saleh

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).